DASATINIB
Tried DASATINIB? Be part of the collective knowledge. Share your experience - your insights help others on their journey.
What Is DASATINIB?
Dasatinib is a potent second-generation tyrosine kinase inhibitor that targets BCR-ABL and Src family kinases. While primarily used as an antineoplastic agent for Philadelphia chromosome-positive leukemias, it is increasingly studied in longevity research as a senolytic due to its ability to selectively induce apoptosis in senescent cells.
DASATINIB Research & Studies
01 Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model ▸
This study demonstrates that the combination of dasatinib and quercetin effectively removes senescent cells, reduces liver fat deposition, and provides anti-fibrotic benefits.
View Study (PubMed)02 Emerging use of senolytics and senomorphics against aging and chronic diseases ▸
A review of how dasatinib acts as a senolytic to eliminate cells in cycle arrest, potentially treating age-related disorders like atherosclerosis and type 2 diabetes.
View Study (PubMed)03 Real‐World Outcomes With Low‐Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia ▸
Research indicates that a lower dose of 50mg may maintain clinical efficacy while significantly improving the safety profile compared to the standard 100mg dose.
View Study (PubMed)04 Drugs induced pulmonary arterial hypertension ▸
This paper identifies dasatinib as a known risk factor for developing severe pulmonary arterial hypertension, which is often reversible upon cessation of the drug.
View Study (PubMed)05 Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism ▸
Study findings suggest that common flavonoids like apigenin can significantly alter the plasma concentration and bioavailability of dasatinib through metabolic interactions.
View Study (PubMed)DASATINIB User Reviews & Experiences
*Based on large scale analysis of publicly available user experiences
Users are highly optimistic about its powerful senolytic 'age-reversal' potential, but the community is deeply cautious due to its profile as a high-potency chemotherapy drug with serious systemic risks.
DASATINIB Benefits, Dosage & Side Effects
- Senescent Cell Clearance: Targeted removal of 'zombie' cells that contribute to systemic inflammation and aging.
- Systemic Inflammation Reduction: Users report a 'reboot' feeling and reduction in chronic aches when used in senolytic protocols.
- Metabolic Improvement: Research suggests potential benefits in liver fat deposition and fibrotic conditions.
- Synergistic Action: Most effective as a longevity tool when combined with Quercetin (the D+Q protocol) to broaden the range of targeted senescent cells.
- Intermittent Efficacy: Unlike daily supplements, it is frequently used in 'pulses' to clear cells without constant systemic exposure.
- Disease Management: Highly effective for imatinib-resistant leukemia, showing deep molecular responses.
- Senolytic Protocol: Common off-label longevity dosage is 100mg taken once weekly or for 2-3 consecutive days once a month.
- Standard Clinical Dose: For leukemia, the approved dose is 100mg daily, though 50mg is increasingly studied for better tolerance.
- Pulse Frequency: Longevity enthusiasts often debate between monthly vs. quarterly cycles to allow for healthy cell recovery.
- Fluid Retention: Risk of pleural effusion (fluid around the lungs) and peripheral edema even at lower doses.
- Hematologic Stress: Potential for myelosuppression, including temporary drops in white blood cell and platelet counts.
- Pulmonary Hypertension: A rare but serious risk of increased blood pressure in the lung arteries.
- Gastrointestinal Distress: Nausea and hemorrhagic colitis have been reported in clinical settings.
- Prescription Only: Heavily regulated as a chemotherapy agent, requiring strict medical supervision.
- High Cost: Traditional pharmaceutical versions are extremely expensive, leading longevity users to seek specialized sourcing or clinical trials.
Related Compounds
Community Reviews
Share your experience with DASATINIB and help others make informed decisions.
Write a Review
Sign in to leave a review